Sequana Medical NV / Financial strength (Piotroski F-Value) /

    The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.

    You are viewing the F-Value as of . Click to view the current F-Value instead.

    Financial strength (Piotroski F-Value)
    2 / 9
    Return on assets (ROA) greater than 0
    close -120.2%
    Operating cash flow greater than 0
    close -$36.32M
    ROA greater than previous year
    close -120.2% ≤ -116.0%
    Cash flow return on assets (CFROA) greater than Return on assets (ROA)
    check -118.3% > -120.2%
    Leverage ratio lower than previous year
    check 27.2% < 28.1%
    Current ratio greater than previous year
    close 321.4% ≤ 359.3%
    No new common stock issued last year
    close $22.77M
    Gross margin greater than previous year
    close -386.5% ≤ -107.9%
    Asset turnover greater than previous year
    close 2.5% ≤ 4.5%

    F-Value history

    The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.

    3
    2
    3
    2
    3
    3
    3
    3
    3
    2
    1
    2
    4
    5
    5
    3
    2
    2
    3
    3
    2
    3

    Notifications